Killian Meara

COVID-19 vaccination before a SARS-CoV-2 infection was associated with a 75% reduced likelihood of long COVID symptoms that impact daily functioning among patients between the ages of 5 and 17 years.

The prevalence of depression and anxiety were also higher among younger patients and those who had a longer duration of pain.

Join Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, for the first episode of Dispensing Leadership, a new podcast from Drug Topics® and RPhAlly.

After adjusting for confounding factors, women who experienced premature menopause had an increased risk of T2D.

Cebranopadol met its primary endpoint of reduction in pain intensity as measured by the Pain Numeric Rating Scale (NRS) area under the curve from 2 through 48 hours.

The main motivations for preferring vaccination included previous experience with an RSV infection and desire to protect the baby.

A discussion with George Van Antwerp, MBA, senior vice president of Product Innovation and Strategic Planning at Prime Therapeutics.

A new study found that GLP-1s were not associated with an increased risk of suicidal ideation, self-harm, or suicide compared to DPP-4 and SGLT-2 inhibitors.

Authors of a research letter published in JAMA said that the decrease in glycemic control may be due to consequences of the COVID-19 pandemic, such as sedentary behavior and increased mental health stressors.

Pharmacy staff members said that VaxCheck was compatible with pharmacy workflow but there were several barriers to its implementation.

Natalie DiPietro Mager, PharmD, PhD, discusses the role that community pharmacists can play in improving access to contraceptive services.

Miudella achieves similar efficacy to other available copper IUDs with less than half the dose of copper.

The technology will be available to patients in the United States in March 2025.

Yesintek from Biocon Biologics and Pyzchiva from Sandoz will have a patient assistance program that includes benefits verification and copay support.

Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.

A program that includes peer coaching and monitoring tools can help pharmacists better manage hypertension in patients.

A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.

A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.

A PDUFA target action date for the PrEP therapy has been set for June 19, 2025.

Among providers who took part in a recent study, 57% reported increased vaccination rates after implementing a quality improvement initiative.

A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.

Multiple micronutrient supplements showed the greatest impact on reducing the risk of giving birth to small vulnerable newborns.

Madison Irwin, PharmD, BCPS, discusses the importance of suzetrigine’s approval in the pain management space and potential challenges or barriers in its adoption.

Help your patients overcome tummy troubles with trusted OTC products that relieve bloating, heartburn, and more, promoting smooth and happy digestion.

Natalie DiPietro Mager, PharmD, PhD, discusses the best ways to integrate maternal health services into the routine workflow of community pharmacies.

RBI-4000 is a self-replicating RNA (srRNA) vaccine developed to stimulate virus-neutralizing immune responses to rabies for prophylactic use.

Investigators from the University of Rhode Island College of Pharmacy discuss 2 studies that assessed perspectives on pharmacist prescribed hormonal contraceptives.

A recent study found that edible or smoked cannabis use predicted little variability in pain relief.

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses key benefits of incorporating biosimilars into a health system's formulary.

Karissa Kim, PharmD, BCPS, BCACP, discusses the main challenges pharmacists face in assessing and addressing patients’ health literacy levels.